# Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

> **NCT02289807** · NA · WITHDRAWN · sponsor: **Sun Yat-sen University**

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT02289807
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2020-08
- **Final completion:** 2022-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289807, "Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02289807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*